InControl Medical Introduces Attain at CES 2019

InControl Medical, LLC announced that Attain, the most advanced over-the-counter device available to treat male and female incontinence and the logical first choice for treatment, will be shown at CES 2019.

FDA clearance for Attain is currently pending.

According to Herschel “Buzz” Peddicord, InControl’s founder and CEO, this revolutionary medical device is designed to help treat the approximately 87 million people suffering with stress, urge, or mixed urinary incontinence, and/or bowel incontinence. Attain provides muscle stimulation, visual biofeedback, and a guided exercise program to solve incontinence at the source – the muscle level.

Attain’s regular self-treatment program, in the privacy of one’s home, eliminates the need for pads, meds, surgery, or diapers. Attain combines the proven methods of electrical muscle stimulation with visual biofeedback, which studies have shown is more effective than biofeedback alone.

InControl representatives will be available at the company’s booth at CES 2019 to explain how Attain works and what makes it the most advanced device of its kind.

Visit InControl at CES 2019 at Sands Halls A-D, Booth #43569.